pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Monte Rosa Therapeutics, Inc. ($GLUE) · news · pharmadog
← back to Monte Rosa Therapeutics, Inc.
News mentioning $GLUE
23
stories
3d
Immunotherapy startup Adecto blames ‘risk-averse funding environment’ for closing down
fiercebiotech
7d
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
biospace
12d
Enveda, an AI drugmaker, banks $311M in venture funding
biopharma dive
Aug 26, 26
Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA
biopharma dive
Aug 26, 26
Research into protein interactions sheds new light on causes of autism
fiercebiotech
Aug 6, 26
With $263M, LifeMine unearths a new drug for organ transplants
biopharma dive
Aug 3, 26
Novo’s late-stage IL-6 stumble shakes inflammation space
biospace
Jul 21, 26
Dimension restocks with $800M to capitalize on AI’s ‘rapid ascent’
biopharma dive
Jun 15, 26
STAT+: Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
stat
Jun 15, 26
Covid vaccination cut risk of adverse heart events, large study finds
stat
Jun 15, 26
STAT+: Lilly’s Ajax acquisition may have been worth it
stat
Jun 12, 26
STAT+: Prometheus raises $12 billion in capital for artificial engineers
stat
Jun 12, 26
STAT+: At hospital finance conference, a call to end the friction that’s keeping costs high
stat
Jun 11, 26
STAT+: An obesity drug deep-dive, and peptides move mainstream
stat
Jun 11, 26
Nonprofit buys experimental cancer drug to maintain patient access
stat
Jun 11, 26
Study highlights influence of socioeconomic status on children’s brain development
stat
Jun 11, 26
STAT+: Abridge inks deals with Nvidia and Lilly
stat
Jun 11, 26
STAT+: A suspicious denial pattern in Medicare Advantage
stat
Jun 11, 26
STAT+: Novartis doubles down on molecular glue strategy
stat
Jun 10, 26
Novartis and Orionis strike second molecular glue deal for $40M upfront
endpoints
May 14, 26
Degron, CREATE, TenNor raise capital; Cabaletta posts CAR-T data
endpoints
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Foghorn cuts workforce by 40%; BioMarin drops 117 roles
fiercebiotech
Dec 22, 25
Fierce Biotech Fundraising Tracker '26: TriGemX tacks on $94M; AnaCardio adds $71M
fiercebiotech
